Men's weight loss injections: separating fact from the noise

The biggest myth: these injections are mainly a women's treatment

This one crops up a lot. It probably traces back to early media coverage, which tended to feature women's stories, and to the fact that weight-loss treatments have historically been marketed that way. The clinical reality is different. The SURMOUNT-1 trial, which tested tirzepatide over 72 weeks and involved thousands of adults with obesity, enrolled men and women; the medicine's mechanism (activating the GIP and GLP-1 receptors that regulate appetite and slow gastric emptying) does not depend on sex. Licensing by the MHRA makes no distinction either. If your BMI and health picture meet the criteria, the medicine may be clinically appropriate, full stop.

That said, body composition does vary. Men typically carry more lean muscle mass and a higher proportion of visceral fat. Visceral fat (the deep abdominal kind) responds well to GLP-1 based treatment, which is one reason some men report noticeable changes around the waist relatively early. This is not a promise of outcomes; individual results depend on starting weight, diet, activity, dose tolerance and other factors your prescriber will consider.

If you want a grounded overview of how a weight loss injection works in general, that page covers the mechanisms without the myths.

What the licensed options are, and how men typically use them

Two injections are currently licensed for weight management in the UK: Mounjaro (tirzepatide, made by Eli Lilly) and Wegovy (semaglutide, made by Novo Nordisk). Both are once-weekly subcutaneous injections, given using a pre-filled pen into the abdomen, thigh or upper arm. Most men find a consistent routine straightforward to maintain, keeping the pen in the fridge door and setting a weekly phone reminder is enough for many people.

Mounjaro activates two receptors (GIP and GLP-1), making it the only dual-agonist weight-loss medicine licensed in the UK. In the SURMOUNT-1 trial, average body-weight reduction reached around 20–21% over 72 weeks at the highest dose, with some analyses reporting higher figures, results that placed it among the most effective pharmacological options studied to date, as noted in NICE's technology appraisal TA1026. Wegovy, a GLP-1 single-agonist, produced around 15% average loss over 68 weeks in the STEP 1 trial.

Treatment with both medicines starts at a low tolerability dose and is titrated upward by the prescriber, typically in four-week steps. The starting dose is not the dose that does the heavy lifting, it exists to let your system adjust before the therapeutic doses begin. Telling a prescriber you want to skip ahead is not how this works; the titration schedule is part of the clinical management, not a formality.

For more detail on the specific injections available, if you want to compare the 3 weight loss injections currently relevant to the UK market, that page sets out what each one involves and how they differ.

Eligibility, side effects and what men most often ask us about

Private eligibility follows the licensed criteria: adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes, obstructive sleep apnoea or cardiovascular disease. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. BMI is the starting point, not the whole picture, a prescriber also looks at your medical history, current medicines and any contraindications.

Side effects are real and worth knowing. The most common are gastrointestinal: nausea, loose stools or constipation, reflux and fatigue, particularly after starting or following a dose increase. For most people these settle within a week or two. The NHS medicines page for tirzepatide lists the full side-effect profile clearly and is worth reading before you begin. Severe, persistent abdominal pain that reaches the back warrants urgent medical attention, the MHRA highlighted acute pancreatitis as a known, infrequent but serious risk associated with GLP-1 medicines.

The question our prescribers hear most often from men specifically is whether these medicines affect testosterone or muscle mass. Current evidence does not suggest a direct hormonal effect on testosterone. Preserving lean muscle while losing fat is important, adequate protein intake and resistance exercise during treatment are recommended by clinical guidelines, and your prescriber can advise further. You can read more about weight loss injections for men, including how the clinical approach accounts for male body composition. Treatment is also not licensed for anyone under 18, and is not recommended for use during any period when a partner is trying to conceive, given guidance on wash-out periods before conception.

If you're weighing up how to access treatment or thinking about cost alongside safety, our treatment page sets out what's included in a private consultation with nume and how the process works from assessment to delivery.

Getting a prescription through a regulated UK pharmacy

These are prescription-only medicines. That means no legitimate route to them exists without a clinical assessment, and any seller offering them without one is operating outside UK law, regardless of how the listing is framed. The MHRA has warned repeatedly about counterfeit weight-loss pens sold online and via social media; fake pens have contained the wrong substances entirely and caused serious harm. You can check whether an online pharmacy is GPhC-registered at the GPhC register before handing over any details.

At nume, every consultation is reviewed the same day by a GPhC-registered Independent Prescriber, a real clinician reads your answers, not software. If approved, treatment is dispatched the same day for free next-working-day tracked delivery, in plain packaging. There are no subscriptions and no auto-renewals; every repeat requires a fresh clinical review. That structure matters for a prescription medicine: ongoing oversight is part of the treatment, not an upsell.

Men often tell us they put this off for months, assuming it wouldn't be available to them or that the process would be complicated. It isn't. If you have been wondering whether women's weight loss injections and men's options differ in any meaningful clinical way, the short answer is that the licensed medicines are the same. This page explains how to get weight loss injections through a regulated provider, step by step. When you're ready, checking your eligibility takes a few minutes.